Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin

Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin

Background. IVIG is occasionally used for preventing and treating severe infections of patients who are to undergo transplantation. Administration of IVIG, which includes high-titer antibodies (Abs) against HLA class I and II, might have a substantial influence on the HLA Ab test results of these pa...

Full description

Bibliographic Details
Main Authors: Hiroyuki Takamatsu, MD, PhD, Shinya Yamada, MD, Noriaki Tsuji, MD, Noriharu Nakagawa, MD, Erika Matsuura, MD, Atsuo Kasada, MD, PhD, Keijiro Sato, MD, Kohei Hosokawa, MD, PhD, Noriko Iwaki, MD, PhD, Masahisa Arahata, MD, Hidenori Tanaka, BS, Shinji Nakao, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2021-06-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001146

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001146

Similar Items